DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $707,843 | -21.5% | 55,648 | -13.1% | 0.00% | -50.0% |
| Q2 2023 | $901,416 | +86.1% | 64,021 | +104.2% | 0.00% | +100.0% |
| Q1 2023 | $484,358 | +20.8% | 31,350 | +346.6% | 0.00% | 0.0% |
| Q4 2020 | $401,000 | -67.1% | 7,019 | -70.5% | 0.00% | -50.0% |
| Q3 2020 | $1,219,000 | +3.4% | 23,759 | +20.3% | 0.00% | 0.0% |
| Q2 2020 | $1,179,000 | +13.6% | 19,743 | -21.7% | 0.00% | 0.0% |
| Q1 2020 | $1,038,000 | -12.3% | 25,211 | +32.6% | 0.00% | +100.0% |
| Q4 2019 | $1,183,000 | +447.7% | 19,013 | +84.4% | 0.00% | – |
| Q4 2018 | $216,000 | – | 10,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |